A discussion titled, “Marijuana is Everywhere. That’s a Problem” with New York Times editorial writers Emily Bazelon, David Leonhardt and German Lopez, who co-wrote Monday’s NYT editorial calling for greater regulation of cannabis, focuses on theory rather than practicality, except when used for prejudicial purposes.
The conversation starts with the clarification that, like the famous NYT editorial series of 2014, theirs is pro-legalization, due to the harms of cannabis prohibition—namely huge numbers of arrests, disproportionately for people of color. They pointed out that they say in the editorial that they oppose the current ballot measure in Massachusetts that would re-criminalize cannabis.
During the discussion, both Leonhardt and Lopez went right away to the fact that things are too loose now because marijuana can be smelled walking down the street. In Lopez’s case he says he was offered a hit on the street in his native Ohio, and Leonhardt talked about the streets of NYC and DC, where he spends time. Leonhardt also seemed distiurbed by the proliferation of cannabis shops in Colorado.Lopez expressed concern that legalization has increased use, drawing on his perspective reporting on the opioid crisis. He was also alarmed that we have “culturally embraced" cannabis. “You see Gwyneth Paltrow investing in Big Weed in CA,” was an example he used, picking up on the prohibitionist organization SAM’s drumbeat about Big Weed.
Much was made of the 2024 NSDUH survey finding that more people smoke cannabis daily than use alcohol, with everyone assuming this meant people get totally stoned all day long. Leonhardt said twice that he “very much likes” alcohol or his martini, and Lopez said he “partakes" himself. But apparently everyone else who uses cannabis does so problematically in their eyes. People who have a problem with pot aren’t productive, and create problems for society, is Lopez's opinion. "We’ve gone way too far it glorifying its use,” he said.
On medical marijuana, while it was acknowledged that some people in pain or with specific ailments might benefit from it, cannabis hasn’t gone through the rigorous studies and government oversight needed to establish it as a true medicine, and we should re-think a system by which cannabis dispensaries sell a product claiming medical use, the speakers said.






